EDELRIS announced that it has signed a multi-year research collaboration with ROCHE
April 4th, 2008: EDELRIS announced that it has signed a multi-year research collaboration with the pharmaceutical group ROCHE.
Edelris
Edelris is dedicated to the design and synthesis of natural product-mimetic compounds
Terms of the agreement
Under the terms of the agreement, Edelris will apply its medicinal chemistry expertise, in combination with its innovative strategies for the synthesis of natural product-like molecules, to design and produce advanced and exclusive high-profile compound series for Roche’s early stages of Discovery.
The CEO's opinion
“Edelris is very proud to enter such an agreement, and we look forward to providing ROCHE with some very promising compounds” commented Dr. Jean-Yves Ortholand, CEO of EDELRIS.
“With Edelris, Roche has identified expertise in the skills and high-level technology they were looking for. We have become one of Roche’s major collaborators in this area due to our in-depth knowledge of Pharmaceutical Research needs, and this is an important recognition of the high level of innovation that has been demonstrated by Edelris over the past three years.”
Further info
Website: www.edelris.com
